Phase I/II study of gemcitabine plus mitoxantrone in advanced breast cancer (ABC)

被引：0
|
作者：
Lorusso, V [1 ]
Catino, A [1 ]
Mancarella, S [1 ]
D'Amico, C [1 ]
Latrorre, A [1 ]
Guida, M [1 ]
Sambiasi, D [1 ]
De Lena, M [1 ]
机构：
[1] Inst Oncol, I-70126 Bari, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81690-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1274
引用
下载
收藏
页码：S317 / S317
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer
    V Lorusso
    E Crucitta
    N Silvestris
    A Catino
    L Caporusso
    A Mazzei
    M Guida
    A Latorre
    D Sambiasi
    C D'Amico
    F Schittulli
    P Calabrese
    M De Lena
    British Journal of Cancer, 2003, 88 : 491 - 495
  • [2] Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer
    Lorusso, V
    Crucitta, E
    Silvestris, N
    Catino, A
    Caporusso, L
    Mazzei, A
    Guida, M
    Latorre, A
    Sambiasi, D
    D'Amico, C
    Schittulli, F
    Calabrese, P
    De Lena, M
    BRITISH JOURNAL OF CANCER, 2003, 88 (04) : 491 - 495
  • [3] Phase I/II study of alternating docetaxel and mitoxantrone with G-CSF support in advanced breast cancer (ABC)
    Kourousis, C
    Androulakis, N
    Kakolyris, S
    Heras, P
    Vardakis, N
    Kotsakis, A
    Kalbakis, C
    Meramveliotakis, N
    Hatzidaki, D
    Samonis, G
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 682 - 682
  • [4] Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study*
    Pier Franco Conte
    Alessandra Gennari
    Sara Donati
    Barbara Salvadori
    Editta Baldini
    Carmelo Bengala
    Ilaria Pazzagli
    Cinzia Orlandini
    Romano Danesi
    Stefano Fogli
    Mario Del Tacca
    Breast Cancer Research and Treatment, 2001, 68 : 171 - 179
  • [5] Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study
    Conte, PF
    Gennari, A
    Donati, S
    Salvadori, B
    Baldini, E
    Bengala, C
    Pazzagli, I
    Orlandini, C
    Danesi, R
    Fogli, S
    Del Tacca, M
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 68 (02) : 171 - 179
  • [6] Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study
    Peter Schmid
    Bernd Flath
    Konstantin Akrivakis
    Volker Heilmann
    Hans-Günther Mergenthaler
    Orhan Sezer
    Rolf Kreienberg
    Kurt Possinger
    Investigational New Drugs, 2005, 23 : 349 - 356
  • [7] Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study
    Schmid, P
    Flath, B
    Akrivakis, K
    Heilmann, V
    Mergenthaler, HG
    Sezer, O
    Kreienberg, R
    Possinger, K
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (04) : 349 - 356
  • [8] Phase II randomized study of gemcitabine plus vinorelbine versus gemcitabine plus mitoxantrone in advanced metastatic breast cancer elderly women: A first-line chemotherapy
    Latorre, A.
    Monticelli, G.
    Giotta, F.
    Calabrese, R.
    Lorusso, V.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII145 - VII146
  • [9] Preliminary results of a phase II study with weekly Paclitaxel and Gemcitabine plus G-CSF in advanced breast cancer (ABC)
    Nistico, Cecilia
    Bria, Emilio
    Cuppone, Federica
    Vanni, Barbara
    Campanella, Carla
    Calabretta, Francesca
    Giannarelli, Diana
    Astorre, Paolo
    Terzoli, Edmondo
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 48
  • [10] Mitoxantrone plus gemcitabine in pretreated patients with advanced breast cancer.
    Onyenadum, A
    Kosmidis, P
    Aravantinos, G
    Bafaloukos, D
    Gogas, H
    Bacoyiannis, C
    Razis, E
    Markopoulos, C
    Makatsoris, T
    Kalofonos, HP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 83S - 83S
12345